734 CASE REPORTS
THE JOURNAL OF BONE AND JOINT SURGERY
CANDIDA SEPTIC ARTHRITIS OF THE HIP IN A YOUNG PATIENT WITHOUT
PREDISPOSING FACTORS
K. Kawanabe, H. Hayashi, M. Miyamoto, J. Tamura, M. Shimizu, T. Nakamura
From Kyoto Senbai Hospital and Kyoto University, Kyoto, Japan
e present a case of septic arthritis of the hip caused by
Candida albicans in a 24-year-old woman. This is the
first report of a Candida infection of the hip in a patient
without any predisposing factors. She underwent a two-stage
total hip arthroplasty three years after the onset of the
infection. An elevated plasma level of β-D-glucan suggested
Candida as the infecting organism and the diagnosis might
have been made earlier if this test had been undertaken at
presentation.
J Bone Joint Surg [Br] 2003;85-B:734-5.
Received 26 September 2002; Accepted after revision 19 December 2002
Septic arthritis caused by Candida species has been described
infrequently and there are usually associated predisposing factors.
1-6 We describe a previously healthy young patient who developed
septic arthritis of the hip caused by Candida albicans and
who underwent a two-stage total hip arthroplasty (THA).
Case report
A 24-year-old woman, with no previous significant medical history,
presented with a three-month history of pain in the right hip.
No specific investigations were undertaken and two years later she
was referred to our hospital. On examination there was tenderness
over the right femoral triangle without erythema, warmth, or swelling.
The movements of the hip were limited. She was afebrile. The
ESR was 56 mm/hr and the level of C-reactive protein 0.5 mg/dl
(normal <0.2 mg/dl). Tests for antinuclear antibodies (ANA),
human immunodeficiency virus and rheumatoid factor were negative.
The levels of serum immunoglobulins and CH50, C3 and C4
were normal.
A radiograph of the hip was normal apart from some osteopenia
of the femoral head. MRI revealed an effusion and synovial hypertrophy.
Culture of synovial fluid revealed a limited growth of Candida
albicans which was thought to be a skin contaminant. The
pain and radiographic destruction of the hip progressed and within
six months she required crutches for walking. There was narrowing
of the joint space and cyst formation (Fig. 1). A resection
arthroplasty of the hip was performed. The synovium and femoral
head grew Candida albicans, the presence of which was confirmed
by the Pas and Grocott stain (Fig. 2). The serum level of β-D-glucan,
which is a marker for fungal infection with a normal value is
<20 pg/ml, was measured by the Fungitec G test MK (Seikagaku
Corp, Tokyo, Japan) and found to be 210 pg/ml two days before
surgery. It decreased to 107 pg/ml ten days after surgery. Treatment
with oral fluconazole (200 mg/day) was started preoperatively.
She continued to use crutches and the level of β-D-glucan
W
Fig. 1
Radiograph of the right hip just before the resection surgery, three years after
the onset of the infection.
Fig. 2
K. Kawanabe, MD, PhD, Associate Professor Candida albicans and synovium (Grocott stain × 248).
J. Tamura, MD, PhD, Assistant Professor
M. Shimizu, MD, PhD, Assistant Professor
T. Nakamura, MD, PhD, Professor
Department of Orthopaedic Surgery, Faculty of Medicine, Kyoto University,
54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
H. Hayashi, MD, PhD, Orthopaedic Surgeon
M. Miyamoto, MD, Orthopaedic Surgeon
Department of Orthopaedic Surgery, Kyoto Senbai Hospital, 447 Maegawacho,
Myohoin, Higashiyama-ku, Kyoto, 605-0932, Japan.
Correspondence should be sent to Dr K. Kawanabe.
©2003 British Editorial Society of Bone and Joint Surgery
doi:10.1302/0301-620X.85B5.13879 $2.00
CASE REPORTS 735
VOL. 85-B, No. 5, JULY 2003
decreased gradually to 22 pg/ml two and half years later, when she
underwent THA. At operation, 100 mg of amphotericin B was
added to 80 g of Endurance bone cement (DePuy CMW, Blackpool,
UK). Specimens of fibrous tissue obtained at surgery showed
no growth of Candida albicans. She was asymptomatic when
reviewed nine months after the operation.
Discussion
Patients who develop septic arthritis with Candida usually have
predisposing factors such as treatment with broad-spectrum
antibiotics1,3,6 or steroids,3,6 immunosuppressive therapy,3,5,6
malignancy,5,6,7 rheumatoid arthritis,2,8 joint aspiration7 or arthroplasty.
9,10 Romero et al11 described a case of Candida septic
arthritis of the knee in an immunocompetent patient who was not a
drug abuser and who had no other predisposing factors. The signs
and symptoms of Candida septic arthritis differ from those of other
causes of septic arthritis. Pain and swelling are present in all
patients but fever, warmth and erythema are rare in those with
Candida septic arthritis.1 The knee is more frequently involved
than the hip or shoulder.6 This case is the first report of involvement
of the hip in a previously healthy young patient without predisposing
factors.
Candida species can be isolated in healthy subjects from the
oral cavity, gastrointestinal tract, vagina, throat, sputum and
perineal skin,1 but rarely from exposed skin.12 The clinical
diagnosis of septic arthritis due to Candida may be difficult
because of the absence of specific signs and symptoms, and the
unusual nature of the organism. However, the presence of a positive
culture for Candida in the synovial fluid should not be
interpreted as a contaminant1,2,6,8 since this delays diagnosis
and treatment.2
β-D-glucan is a constituent of fungi and elevated plasma levels
are common in patients with mycosis or fungaemia.13 Serological
kits with proven clinical application have been developed for the
rapid diagnosis of mycoses.14 In this case, early diagnosis and a
better prognosis might have been possible if the serum β-D-glucan
level had been measured at the time of presentation.
No benefits in any form have been received or will be received from a commercial
party related directly or indirectly to the subject of this article.
References
1. Noyes FR, McCabe J, Fekety FR Jr. Acute Candida arthritis: report of a
case and use of amphotericin B. J Bone Joint Surg [Am] 1973;55-A:169-76.
2. Graham DR, Frost HM. Candida guilliermondi infection of the knee
complicating rheumatoid arthritis: a case report. Arthritis Rheum
1973;16:272-7.
3. Specht EE. Candida pyarthrosis of the hip and renal transplantation:
report of a case treated by femoral head and neck resection and 5-fluorocytosine.
Clin Orthop 1977;126:176-7.
4. Pope TL. Pediatric Candida albicans arthritis: case report of hip
involvement with a review of the literature. Prog Pediatr Surg
1982;15:271-83.
5. Nouyrigat P, Baume D, Blaise D, et al. Candida arthritis treated with
intra-articular amphotericin B. Eur J Med 1993;2:124-5.
6. Cuende E, Barbadillo C, E-Mazzucchelli R, et al. Candida arthritis in
adult patients who are not intravenous drug addicts: report of three cases
and review of the literature. Semin Arthritis Rheum 1993;22:224-41.
7. Kanai K, Sekiya J, Noro T, et al. Two cases of Candida arthritis of the
knee. Seikeigeka Saigaigeka 1996;39:1179-82.
8. Campen DH, Kaufman RL, Beardmore TD. Candida septic arthritis
in rheumatoid arthritis. J Rheumatol 1990;17:86-8.
9. Youskin S, Evarts M, Steigbigegl R. Candida parapsilosis infection of
a total hip joint replacement: successful reimplantation after treatment
with amphotericin B and 5-fluorocytosine. J Bone Joint Surg [Am]
1984;66-A:142-3.
10. Levine M, Rehm SJ, Wilde AH. Infection with Candida albicans of a
total knee arthroplasty: case report and review of the literature. Clin
Orthop 1988;226:235-9.
11. Romero JMC, Vega JLA, Vallinas JMS, Alberdi RO. Candida arthritis
in an immunocompetent patient without predisposing factors. Clin
Rheum 1998;17:393-4.
12. Marples MJ. The normal flora of the human skin. Br J Dermatol
1969;81(Suppl 1):2-13.
13. Yoshida M, Roth RI, Grunfeld C, Feingold KR, Levin J. Soluble
(1→3)-β-D-glucan purified from Candida albicans: biologic effects and
distribution in blood and organs in rabbits. J Lab Clin Med
1996;128:103-14.
14. Miyazaki T, Kohno S, Mitsutake K, et al. Plasma (1→3)-β-D-glucan
and fungal antigenemia in patients with candidemia, aspergillosis and
cryptococcosis. J Clin Microbiol 1995;33:3115-8
No comments:
Post a Comment